ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $43,445,336 | +0.1% | 2,758,434 | 0.0% | 0.83% | +3.1% |
| Q3 2022 | $43,418,000 | +33.7% | 2,758,434 | +18.6% | 0.81% | +37.1% |
| Q2 2022 | $32,464,000 | +19.2% | 2,325,500 | +47.2% | 0.59% | +33.0% |
| Q1 2022 | $27,237,000 | +90.0% | 1,579,900 | +60.2% | 0.44% | +140.2% |
| Q4 2021 | $14,335,000 | +22.2% | 985,900 | +51.3% | 0.18% | +42.6% |
| Q3 2021 | $11,732,000 | +84.6% | 651,783 | +80.1% | 0.13% | +101.6% |
| Q2 2021 | $6,357,000 | – | 362,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
| MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
| Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
| Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
| Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
| EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
| Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
| Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
| Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
| Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |